Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation

Endocrine-Related Cancer

Volumn 18, Issue 3, 2011, Pages 347-356

  Villa, Chiara ^a,b   Lagonigro, Maria Stefania ^b   Magri, Flavia ^b   Koziak, Maria ^c   Jaffrain Rea, Marie Lise ^d,e   Brauner, Raja ^f   Bouligand, Jerome ^g   Junier, Marie Pierre ^a   Di Rocco, Federico ^h   Sainte Rose, Christian ^h   Beckers, Albert ⁱ   Roux, François Xavier ^c   Daly, Adrian F ⁱ   Chiovato, Luca ^b  

^a INSERM   (France)

^b UNIVERSITY OF PAVIA   (Italy)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e IRCCS NEUROMED   (Italy)

^f BICÊTRE HOSPITAL   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN GENE; CARCINOGENESIS; CASE REPORT; DIABETES INSIPIDUS; EMERGENCY WARD; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; TWINS;

ADENOMA; ADOLESCENT; BASE SEQUENCE; DISEASE PROGRESSION; DISEASES IN TWINS; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; HYPERPLASIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSS OF HETEROZYGOSITY; MALE; MUTATION; PEDIGREE; PITUITARY GLAND;

EID: 79960088936     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0059     Document Type: Article

References (31)

1. Agarwal SK, Ozawa A, Mateo CM & Marx SJ 2009 The MEN1 gene and pituitary tumours. Hormone Research 71 (Supplement 2) 131-138. (doi:10.1159/000192450)
2. Asa SL 2008 Practical pituitary pathology: what does the pathologist need to know? Archives in Pathology and Laboratory Medicine 132 1231-1240.
3. Asa SL & Ezzat S 2009 The pathogenesis of pituitary tumors. Annual Review of Pathology 4 97-126. (doi:10.1146/annurev.pathol.4.110807.092259)
4. Bazzi W, Renon M, Vercherat C, Hamze Z, Lacheretz- Bernigaud A, Wang H, Blanc M, Roche C, Calender A, Chayvialle JA et al. 2008 MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells. Gastroenterology 135 1698.e2-1709.e2. (doi:10.1053/j.gastro.2008.07.031)
5. Beckers A & Daly AF 2007 The clinical, pathological, and genetic features of familial isolated pituitary adenomas. European Journal of Endocrinology 157 371-382. (doi:10.1530/EJE-07-0348)
6. Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Rene-Corail F, Stergiopoulos S, Bourdeau I et al. 2009 Mutations in regulatory subunit type 1A of cyclic adenosine 50-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. Journal of Clinical Endocrinology and Metabolism 94 2085-2091. (doi:10.1210/jc.2008-2333)
7. Boikos SA & Stratakis CA 2006 Pituitary pathology in patients with Carney complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary 9 203-209. (doi:10.1007/s11102- 006-0265-2)
8. Cazabat L, Guillaud-Bataille M, Bertherat J & Raffin-Sanson ML 2009 Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas. Hormone Research 71 132-141. (doi:10.1159/000197869)
9. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA & Beckers A 2006 High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Journal of Clinical Endocrinology and Metabolism 91 4769-4775. (doi:10.1210/jc.2006-1668)
10. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G et al. 2007 Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism 92 1891-1896. (doi:10.1210/jc.2006-2513)
11. Daly AF, Tichomirowa MA & Beckers A 2009a Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma. Hormone Research 71 (Supplement 1) 105-111. (doi:10.1159/000178050)
12. Daly AF, Tichomirowa MA & Beckers A 2009b Genetic, molecular and clinical features of familial isolated pituitary adenomas. Hormone Research 71 (Supplement 2) 116-122. (doi:10.1159/000192448)
13. Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A et al. 2010 Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an International collaborative study. Journal of Clinical Endocrinology and Metabolism 95 E373-E383. (doi:10.1210/jc.2009- 2556)
14. Dumitrescu CE & Collins MT 2008 McCune-Albright syndrome. Orphanet Journal of Rare Diseases 3 12. (doi:10.1186/1750-1172-3-12)
15. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML & McCutcheon IE 2004 The prevalence of pituitary adenomas: a systematic review. Cancer 101 613-619. (doi:10.1002/cncr.20412)
16. Fernandez A, Karavitaki N &Wass JA 2010 Prevalence of pituitary adenomas: a community-based, cross-sectional study inBanbury (Oxfordshire, UK). Clinical Endocrinology 72 377-382. (doi:10.1111/j.1365-2265.2009.03667.x)
17. Heliovaara E, Raitila A, Launonen V, Paetau A, Arola J, Lehtonen H, Sane T, Weil RJ, Vierimaa O, Salmela P et al. 2009 The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas. American Journal of Pathology 175 2501-2507. (doi:10.2353/ajpath.2009.081131)
18. Jaffrain-Rea ML, Angelini M, Gargano D, Tichomirowa MA, Daly AF, Vanbellinghen JF, D'Innocenzo E, Barlier A, Giangaspero F, Esposito V et al. 2009 Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocrine-Related Cancer 16 1029-1043. (doi:10.1677/ERC-09-0094)
19. Kovacs K, Horvath E, Thorner MO & Rogol AD 1984 Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis. Virchows Archiv. A, Pathological Anatomy and Histopathology 403 77-86. (doi:10.1007/BF00689340)
20. Kristiansen G 2010 Manual microdissection. Methods in Molecular Biology 576 31-38. (doi:10.1007/978-1-59745-545-9-2)
21. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J et al. 2008 The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 93 2390-2401. (doi:10.1210/jc.2007-2611)
22. Magri F, Villa C, Locatelli D, Scagnelli P, Lagonigro MS, Morbini P, Castellano M, Gabellieri E, Rotondi M, Solcia E et al. 2010 Prevalence of double pituitary adenomas in a surgical series: clinical, histological and genetic features. Journal of Endocrinological Investigation 33 325-331. (doi:10.3275/6716)
23. Osamura RY, Kajiya H, Takei M, Egashira N, Tobita M, Takekoshi S & Teramoto A 2008 Pathology of the human pituitary adenomas. Histochemistry and Cell Biology 130 495-507. (doi:10.1007/s00418-008-0472-1)
24. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA & Stratakis CA 2000 Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex). Journal of Clinical Endocrinology and Metabolism 85 3860-3865. (doi:10.1210/jc.85.10.3860)
25. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J & Atkinson MJ 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 103 15558-15563. (doi:10.1073/pnas.0603877103)
26. Raitila A, Lehtonen HJ, Arola J, Heliövaara E, Ahlsten M, Georgitsi M, Jalanko A, Paetau A, Aaltonen LA & Karhu A 2010 Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression. American Journal of Pathology 177 1969-1976. (doi:10.2353/ajpath.2010.100138)
27. Scheithauer BW, Kovacs KT, Stefaneanu L, Horvath E, Kane LA, Young WF Jr, Lloyd RV, Randall RV & Davis DH 1995 The pituitary in gigantism. Endocrine Pathology 6 173-187. (doi:10.1007/BF02739881)
28. Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M, Verma S, Daly AF, Raygada M, Keil MF et al. 2010 The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clinical Genetics 78 457-463. (doi:10.1111/j.1399-0004.2010.01406.x)
29. Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Verges B et al. 2008 Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. American Journal of Surgical Pathology 32 534-543. (doi:10.1097/PAS.0b013e31815ade45)
30. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R et al. 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 1228-1230. (doi:10.1126/science.1126100)
31. Villa C, Magri F, Morbini P, Falchetti A, Scagnelli P, Lovati E, Locatelli D, Canevari FR, Necchi V, Gabellieri E et al. 2008 Silent familial isolated pituitary adenomas: histopathological and clinical case report. Endocrine Pathology 19 40-46. (doi:10.1007/s12022-008-9018-2)